Articles tagged with Microbial Infections
A new study provides a method to estimate sample size required for microbiome studies based on effect sizes and analysis methods. For strong associations, around 500 participants were needed to achieve 80% statistical power, while weaker associations may require thousands of samples.
A new class of antibiotic has been shown to be effective in treating MRSA infections, with a daily dose of epidermicin NI01 demonstrating equal efficacy to the current standard of care. The findings justify further pre-clinical development and could lead to new gel-type therapies for skin infections.
A Chinese Academy of Sciences research team has identified the first mechanism of citrus resistance to citrus greening disease and developed an AI-assisted therapeutic approach. The discovery addresses the challenge of naturally occurring resistant genes in citrus, offering hope for global agricultural sustainability.
The new season of The Last of Us explores the real-life characteristics of cordyceps, including its airborne spore method of infection. Researchers like Dr. Jim Kronstad highlight the warming climate as a potential contributor to the spread of harmful fungi.
The American College of Chest Physicians' CHEST Critical Care and CHEST Pulmonary journals have been indexed in Elsevier's Scopus database. This achievement is a testament to the high-quality research published in these journals, which provide open access content in pulmonary and critical care medicine.
Researchers have developed a novel approach to detect Fusarium wilt in tomato plants by analyzing subtle changes in water use, allowing for early detection before visual symptoms appear. This method provides a quantitative approach to assess disease severity, pathogen virulence, and plant susceptibility.
Researchers developed a transformation process to boost H₂Sₙ yield from garlic-derived compounds, achieving significant H. pylori eradication outcomes. The use of chitosan-encapsulated microreactors demonstrated enhanced efficacy and faster eradication rates compared to conventional methods.
Recent research challenges the traditional distinction between functional dyspepsia (FD) and gastroparesis (GP), suggesting they represent a continuum of the same disease. The review highlights significant symptom overlap, shared pathophysiological mechanisms, and potential therapeutic strategies.
A new study published in Microorganisms explores the impact of starch on oral health and finds that high AMY1 copy numbers alter the oral microbiome, increasing disease risk. The researchers discovered that populations with a history of agriculture and starch consumption have more copies of the gene, which provides a survival advantage.
Dr. Jonathan Cox warns of the dangers of raw sewage in UK coastal waters, highlighting the risk of gastrointestinal, respiratory, and skin infections to vulnerable groups. He advocates for checking water quality before visiting beaches and praises efforts like the Safer Seas and Rivers Service to combat pollution.
A new global guideline has been published to manage fungal infections caused by Candida, affecting millions worldwide annually. The guideline establishes standards for prevention, diagnosis, and innovative treatment approaches.
A Dartmouth-led study reveals that cystic fibrosis disrupts the maturation of the gut microbiome in infants, leading to a depletion of health-associated bacteria and potentially poor health outcomes. The study found that the microbiomes of infants with CF remained stunted or delayed in their development compared to healthy infants.
Researchers found that flagellin from the gut disrupts immune checkpoint treatment in ovarian cancer patients. Inhibiting this pathway may enhance clinical outcomes and save lives. The discovery could lead to novel therapies capable of targeting ovarian tumors.
Researchers at TUM have developed a new therapeutic approach combining dietary therapy with fecal microbiome transfer to sustain inflammation-free states in Crohn's disease patients. The study found that the gut microbiome changes as a result of dietary therapy contribute to treatment success.
A new retrospective study found that nearly half of patients with fever of unknown origin in sub-Saharan Africa had a detectable pathogen, including bacterial strains and hemorrhagic fever viruses. The study highlights the need for strengthened laboratory capacity to improve diagnosis and treatment.
A study found that two liver graft preservation methods differ in their effect on gut microbiota composition and function following liver transplantation. The NMP cohort showed enrichment of beneficial gut taxa, while the static cold storage cohort depleted such taxa. Notable differences were observed between the two preservation methods.
A new Weizmann Institute study identified all proteins in a stool sample – those from the microbiome, human body, and food – revealing secrets of the intestines and their impact on human disease. The method, dubbed IPHOMED, decodes microbiome activity by showing which proteins come from bacterial strains and amounts.
A comprehensive study reveals that Akkermansia muciniphila breaks down sugars locked in mucus using a set of enzymes. The findings provide new insights into the molecular mechanisms behind this process and its potential applications in understanding disease and improving gut health.
A study published in Pediatric Investigation found that microbial cell-free DNA testing predicted infectious organisms consistent with traditional culturing tests in 26.9% of pediatric patients, but its utility was variable due to factors like antibiotic exposure and contamination.
Researchers at John Innes Centre have discovered a biological mechanism that enhances partnerships between plant roots and soil microbes, increasing nutrient uptake. This finding holds great potential for advancing sustainable agriculture by reducing the need for inorganic fertilizers.
A new self-destructing vaccine provides improved safety and protection against TB in macaque monkeys, outperforming the standard BCG vaccine. The 'kill switch' mechanism eliminates the risk of accidental infection, offering a safer vaccination option for immunocompromised individuals.
Scientists at University of California - Riverside discovered a chemical produced by plants that prevents bacterial biofilm formation. This breakthrough offers potential advances in healthcare and industrial settings, where biofilms cause significant problems.
A study by Michigan Medicine researchers suggests that sulfur-producing bacteria may be behind lingering Crohn's disease symptoms, even in the absence of inflammation. The study found that these bacteria can lead to increased visceral hypersensitivity and altered intestinal permeability, contributing to persistent symptoms.
Engineered yeast cells can form cooperative groups that perform complex tasks and self-regulate in response to external signals. This approach enables precise production of therapeutic compounds, reducing waste and increasing treatment efficacy.
A six-year study examining 38 clinical isolates of Cryptococcus found genes and gene alleles associated with disease severity. The research aims to develop new treatments targeting these genetic variations, predicting disease outcomes and improving patient care.
Pusan National University researchers have identified genes that are overexpressed in peri-implantitis, a condition similar to periodontitis but with higher recurrence rates. The study's findings may help diagnose and treat the disease with targeted therapies.
Researchers identified a protein that inhibits human defense mechanisms and allows fungal growth. The study suggests that the lack of this enzyme makes the fungus more prone to elimination by the immune system.
A recent machine learning study suggests that the association between gut bacteria and disease may be overstated. Instead, changes in microbial load were found to be a key factor in the presence of disease-associated microbial species. This discovery challenges current understanding of the gut microbiome's role in disease etiology.
Researchers at Houston Methodist have identified a new strain of bacteria, Streptococcus dysgalactiae subspecies equisimilis (SDSE), linked to increasingly severe human infections. The study used integrative analysis to investigate the genome, transcriptome, and virulence of SDSE strains, shedding light on their molecular pathogenesis.
A new study found compositional and functional differences in the gut microbiota of Chinese long-living adults (over 90 years) compared to elderly adults (65–74 years). The researchers noted lower relative abundances of bacteria in certain genera, which may regulate biological processes like autophagy and telomere maintenance. These fi...
A new study has found that rifaximin, an antibiotic commonly prescribed for liver disease patients, is driving the emergence of a deadly superbug. The antibiotic triggers specific changes in bacteria that make them resistant to last-resort antibiotics like daptomycin.
Researchers found that the presence of a fungus increases the pH of the soil, promoting growth of beneficial bacteria. This interaction could lead to sustainable agricultural practices by harnessing microbial interactions to combat plant diseases.
A new study reveals how three species of bacteria coexist in biofilms by playing a game of 'nice' and then moving out when the surface becomes too crowded. The dominant species, Pseudomonas aeruginosa, disperses to allow other species to thrive.
Researchers will showcase results of a randomized clinical trial demonstrating Biovanta's efficacy in reducing common cold symptoms by strengthening the respiratory barrier and controlling inflammation. The presentation will also include preclinical data on antiviral formulas targeting rhinovirus and influenza.
Researchers have discovered that Listeria monocytogenes loses its cell wall and becomes round when entering a dormant state, making it undetectable by growth-based tests. Developing antibodies to detect dormant forms of the bacterium could lead to specific tests for better protection.
A new study published in PNAS suggests that delivering microparticles containing CCL2 directly to the gums can inhibit bone loss and speed up bone repair in a mouse model of periodontal disease. The therapy modulates the immune response, shifting macrophages from inflammatory M1 type to anti-inflammatory M2 type.
Researchers have conducted the largest genomic survey of the syphilis bacterium to date, correlating genetic data with clinical information to identify potential targets for a vaccine. The study found differences in bacterial strains between continents, but also similarities that suggest a global vaccine could be effective.
Researchers at WVU are working on a project to inhibit the myeloperoxidase enzyme, which feeds pancreatic cancer growth. By targeting this enzyme, they hope to boost the body's immune system to fight cancer, showing promise in mouse models and potential for future clinical trials.
A study led by Cesar de la Fuente and his team has uncovered sequences for infection-fighting molecules in the genomic data of extinct species. These ancient β-defensins may lead to the creation of new antimicrobial therapies, including antibacterial, antifungal, and antiviral treatments.
A study by researchers from Brazil and Germany found that a surface protein on Aspergillus fumigatus spores suppresses the release of pro-inflammatory substances by immune cells, making it easier for the fungus to infect the body. The enzyme glycosylasparaginase plays a crucial role in this process.
A subset of CD4 T cells create an anti-inflammatory environment within the lung tissue, protecting against TB reinfection by limiting bacterial growth and disease severity. The discovery complements previous research on protective immune T cells in controlling TB infection, suggesting a potential key to improving existing vaccines.
Researchers identify accessory genes linked to nitric oxide production that contribute to Foc TR4's virulence, offering potential treatments and strategies to slow its spread. Monocropping is also identified as a key factor in the disease's success, highlighting the importance of crop diversity.
A new index uses inflammatory cell proportions to predict tissue healing and outcomes in patients with ulcerative colitis. The index, called the inflammatory cell enumeration index (ICEI), was developed by analyzing data from 220 patients who achieved healing.
Researchers found that certain flu viruses can use a second entry pathway, MHC class II protein complexes, to infect human and animal cells. This ability helps the viruses infect different species and potentially jump between animals and humans.
Researchers identify key steps in Pseudogymnoascus destructans infection, including epidermal growth factor receptor co-optation and manipulation of keratinocytes. The discovery opens potential treatment possibilities using FDA-approved drug gefitinib.
The team created stable microbial therapeutics using synthetic extremophiles, maintaining potency and function over time despite extreme temperatures and harsh manufacturing processes. These formulations have potential applications in healthcare, agriculture, and space exploration.
Researchers have identified 31 effector genes from the fungus Ceratocystis fimbriata, which causes devastating black rot in sweetpotatoes. This breakthrough provides a new approach to developing disease-resistant crops using effector-assisted breeding.
Researchers uncover how grafting onto resistant rootstocks changes root exudates, reducing pathogenic Agrobacterium and enhancing plant defense mechanisms. The study suggests grafting can minimize chemical pesticide use, boosting eco-friendly farming and crop health.
A study from the University of Notre Dame identifies fibrinolytic deficiencies as a key factor increasing risk for catheter-associated urinary tract infections (CAUTIs) and sepsis in catheterized patients. The research suggests that antifibrinolytic medications may be linked to this increased risk.
A team of researchers created a microfluidic human cervix model that replicates the complex interactions between cervical epithelial cells, mucus production, and microbiome. The Cervix Chip technology offers a new testbed for bacterial vaginosis therapeutics and other treatments, addressing a key women's health gap.
A new study highlights the benefits of intermittent fasting and protein-pacing on gut health, weight loss, and metabolic responses. Participants showed improved diversity of the gut microbiota, decreased symptoms of gastrointestinal problems, and increased beneficial microbes linked to a lean body type.
Researchers created a new model to study the effects of undernutrition on the microbiome, which can help identify specific microbes that impact development. The model mimics early childhood experiences and shows promise in understanding the underlying causes of stunted growth and other harmful effects of undernutrition.
Astragalus polysaccharide regulates VRC metabolism by increasing Bifidobacterium bifidum abundance and reducing inflammation in the liver. This leads to improved VRC metabolism, with high-dose APS showing stronger effects.
Researchers found that gut bacteria-generated linoleic acid metabolite KetoC markedly reduced inflammation and immune cell expansion. gKetoC also suppressed prolonged T-cell proliferation and dendritic cell activation. The study suggests a potential molecular axis governing the immunomodulatory effects of gKetoC.
Researchers at U of T have identified two compounds, diindolylmethane and diindolylethane, produced by gut bacteria that can regulate the nuclear receptor CAR, potentially treating diseases like diabetes, fatty liver disease, and small intestine ulcerative colitis.
Researchers at George Mason University have developed a urine test for Lyme disease that detects the bacteria causing the infection, leading to earlier treatment and prevention of long-term debilitating effects. The test has shown high sensitivity and specificity, and will be made available through telehealth to increase accessibility.
Researchers found that altering a male mouse's gut microbiota increases the probability of low birth weight and premature death in their offspring. The study suggests a 'gut-germline axis' exists, connecting the gut microbiota to the germline and potentially influencing inherited traits.
Decreased gut bacterial diversity was found in patients with NAFLD, while Faecalibacterium and Ruminococcus 2 were associated with the disease. The study identified a combination of microbiomes and biochemical indexes that distinguished NAFLD from normal livers.
Grafting onto a disease-resistant rootstock reduces pathogenic Agrobacterium abundance and alters the microbiome composition, enriching beneficial bacteria. The decreased valine in root exudates from grafted plants contributes to decreasing Agrobacterium abundance and suppressing crown gall disease.
A new study reveals that gut microbiota significantly impacts host amino acid and glucose metabolism, leading to a second liver-like function. The research identifies specific bacterial metabolic genes responsible for depleting amino acids, which can be targeted to treat conditions such as type 2 diabetes and inflammatory bowel disease.